By Keeping Vitamin A Active Drug Slows Prostate Tumor Growth

A novel compound that blocks the breakdown of retinoic acid, derived from vitamin A, is a surprisingly effective and “promiscuous” agent in treating animal models of human prostate cancer, say investigators from the University of Maryland, Baltimore (UMB).Daily injections of the agent VN/14-1 resulted in up to a 50 percent decrease in tumor volume in mice implanted with human prostate cancer cells, reported Aakanksha Khandelwal, Ph.D. [click link for full article]

More: continued here

Filed under: Biology on November 8th, 2007